Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Humane Genomics, a biotechnology company developing oncolytic viral therapies, today announced a partnership for process transfer and cGMP manufacturing of HGI627, a novel therapy targeting pediatric liver cancer (hepatoblastoma). https://mma.prnewswire.com/media/2679070/Genezen_Logo_RGB_Logo.jpg Humane Genomics uses its proprietary synthetic RNA virus platformto rapidly design and engineer […]

Ribbon Communications Inc. (Nasdaq: RBBN), a global leader in real-time communications technology and IP optical networking solutions, today announced the successful completion of a 20Tbps optical transmission field trial on the 10,000 km JUNO trans-Pacific submarine cable, developed and operated by Seren Juno. Ribbon's mission is to help service providers, enterprises and critical infrastructure operators

Uptop-a card-linked rewards platform-is expanding beyond sports to offer rewards across retail, entertainment, travel, dining, and more. Rain, the enterprise-grade infrastructure for stablecoin-powered payments, today announced it has acquired Uptop, an onchain rewards platform that turns everyday card purchases into loyalty for users, brands, and sponsors through simple card linking and receipt scanning. https://mma.prnewswire.com/media/2697289/Rain_Logo.jpg The

New AI Orchestrator Platform Delivers Enterprise-wide Video Intelligence at Unprecedented Accessibility, Unlocking Operational Insights and Eliminating System Overhauls. IPTECHVIEW launches its next-generation cloud video management platform with AI Orchestrator, which harnesses the power of cloud-based video intelligence and generative Video AI. IPTECHVIEW AI extends far beyond conventional security cameras to deliver comprehensive video supervision powered

Polkadot Capital Group, the capital-markets focused division ofPolkadot, andBlockdaemon, a leading institutional-grade blockchain infrastructure provider, today announced a strategic collaboration to enable the institutional investment community with compliant access to opportunities across the blockchain ecosystem and the wider web3 landscape. Driven by escalating demand, the initiative addresses the gap between traditional finance (TradFi) and decentralized

2026GlobalGrantMakingIncreases to 57 Organizations Up From 32 The Previous Year NAMM(The National Association of Music Merchants), the largest global non-profit music trade organization, and the NAMM Foundation have announced over $800,000 in grants to 57 deserving charitable organizations, which represents the largest number of grants ever given to organizations from across all industry segments. The

(NYSE MKT:GNS), SINGAPORE, Nov. 12, 2025 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced the appointment of Inspiral Architects for the iconic design of Genius City in Bali. Inspiral Architects are an award-winning architecture firm renowned for inspiring, organic, nature-based design.

(NASDAQ:NXTC), BELTSVILLE, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to developing novel therapies to treat cancer, today announced that it has entered into definitive agreements with the participation of certain institutional and accredited investors, including Ikarian Capital, Squadron Capital Management, Affinity Healthcare Fund, LP., Exome Asset

(NASDAQ:AERT), NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — Aeries Technology, Inc. (NASDAQ: AERT) (“Aeries” or the “Company”), a global leader in AI-powered business transformation and Global Capability Center (GCC) services, today announced that it held its Second Quarter Fiscal Year 2026 Earnings Call earlier in the week. Chief Executive Officer Ajay Khare and Chief

(NYSE:ANVS), MALVERN, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today provided corporate updates and third quarter 2025 financial results. “The past quarter delivered breakthrough progress